| Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis L Richeldi, RM Du Bois, G Raghu, A Azuma, KK Brown, U Costabel, ... New England Journal of Medicine 370 (22), 2071-2082, 2014 | 5236 | 2014 |
| ERS clinical practice guidelines on treatment of sarcoidosis RP Baughman, D Valeyre, P Korsten, AG Mathioudakis, WA Wuyts, ... European Respiratory Journal 58 (6), 2021 | 616 | 2021 |
| The WASOG sarcoidosis organ assessment instrument: an update of a previous clinical tool MA Judson, U Costabel, M Drent, A Wells, L Maier, L Koth, H Shigemitsu, ... Sarcoidosis Vasc Diffuse Lung Dis 31 (1), 19-27, 2014 | 601 | 2014 |
| MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease PA Juge, JS Lee, E Ebstein, H Furukawa, E Dobrinskikh, S Gazal, ... New England Journal of Medicine 379 (23), 2209-2219, 2018 | 559 | 2018 |
| Multicentre evaluation of multidisciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: a case-cohort study SLF Walsh, AU Wells, SR Desai, V Poletti, S Piciucchi, A Dubini, H Nunes, ... The lancet Respiratory medicine 4 (7), 557-565, 2016 | 518 | 2016 |
| Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial SCA Meijvis, H Hardeman, HHF Remmelts, R Heijligenberg, GT Rijkers, ... The Lancet 377 (9782), 2023-2030, 2011 | 492 | 2011 |
| Nintedanib with add-on pirfenidone in idiopathic pulmonary fibrosis. Results of the INJOURNEY trial C Vancheri, M Kreuter, L Richeldi, CJ Ryerson, D Valeyre, JC Grutters, ... American journal of respiratory and critical care medicine 197 (3), 356-363, 2018 | 339 | 2018 |
| Surfactant protein C mutations are the basis of a significant portion of adult familial pulmonary fibrosis in a dutch cohort CHM van Moorsel, MFM van Oosterhout, NP Barlo, PA de Jong, ... American journal of respiratory and critical care medicine 182 (11), 1419-1425, 2010 | 333 | 2010 |
| Methotrexate vs azathioprine in second-line therapy of sarcoidosis ADM Vorselaars, WA Wuyts, VMM Vorselaars, P Zanen, VHM Deneer, ... Chest 144 (3), 805-812, 2013 | 290 | 2013 |
| Corticosteroid treatment in sarcoidosis JC Grutters, JMM Van den Bosch European Respiratory Journal 28 (3), 627-636, 2006 | 265 | 2006 |
| Serum soluble interleukin-2 receptor measurement in patients with sarcoidosis: a clinical evaluation JC Grutters, JM Fellrath, L Mulder, R Janssen, JMM van den Bosch, ... Chest 124 (1), 186-195, 2003 | 244 | 2003 |
| HLA-DQB1* 0201: a marker for good prognosis in British and Dutch patients with sarcoidosis H Sato, JC Grutters, P Pantelidis, AN Mizzon, T Ahmad, AJ Van Houte, ... American journal of respiratory cell and molecular biology 27 (4), 406-412, 2002 | 216 | 2002 |
| Human neutrophils switch to an activated phenotype after homing to the lung irrespective of inflammatory disease E Fortunati, KM Kazemier, JC Grutters, L Koenderman, ... Clinical & Experimental Immunology 155 (3), 559-566, 2009 | 195 | 2009 |
| Increased frequency of the uncommon tumor necrosis factor− 857T allele in British and Dutch patients with sarcoidosis JC Grutters, H Sato, P Pantelidis, AL Lagan, DS McGrath, JWJ Lammers, ... American journal of respiratory and critical care medicine 165 (8), 1119-1124, 2002 | 184 | 2002 |
| Systemic cytokine response in patients with community-acquired pneumonia H Endeman, SCA Meijvis, GT Rijkers, H van Velzen–Blad, ... European Respiratory Journal 37 (6), 1431-1438, 2011 | 178 | 2011 |
| Combination therapy: the future of management for idiopathic pulmonary fibrosis? WA Wuyts, KM Antoniou, K Borensztajn, U Costabel, V Cottin, B Crestani, ... The lancet Respiratory medicine 2 (11), 933-942, 2014 | 176 | 2014 |
| Delphi consensus recommendations for a treatment algorithm in pulmonary sarcoidosis FF Rahaghi, RP Baughman, LA Saketkoo, NJ Sweiss, JB Barney, ... European Respiratory Review 29 (155), 2020 | 175 | 2020 |
| New treatment strategies for pulmonary sarcoidosis: antimetabolites, biological drugs, and other treatment approaches RP Baughman, JC Grutters The Lancet Respiratory Medicine 3 (10), 813-822, 2015 | 169 | 2015 |
| Defining the clinical outcome status (COS) in sarcoidosis: results of WASOG Task Force RP Baughman, S Nagai, M Balter, U Costabel, M Drent, R Du Bois, ... Sarcoidosis vasc diffuse lung dis 28 (1), 56-64, 2011 | 169 | 2011 |
| Whole lung lavage therapy for pulmonary alveolar proteinosis: a global survey of current practices and procedures I Campo, M Luisetti, M Griese, BC Trapnell, F Bonella, J Grutters, ... Orphanet journal of rare diseases 11 (1), 115, 2016 | 167 | 2016 |
Coline van MoorselSt Antonius ILD center of ExcellenceVerified email at antoniusziekenhuis.nl
